Updated:
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001563577, and its reported...
Overview
Galera Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001563577, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-19, it reported net income of USD 149,049,000; total assets of USD 7,196,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Galera Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Malvern, PA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001563577
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2025USD | $149.0M | $7.2M | $6.4M | -$6.0M | |
| FY2024USD | -$19.0M | $10.1M | $8.3M | -$12.1M | |
| FY2023USD | -$59.1M | $26.1M | $18.3M | -$44.8M | |
| FY2022USD | -$62.2M | $44.0M | $4.3M | -$43.4M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Galera Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.